Crohn Disease Clinical Trials in Chicago, Illinois
4 recruitingChicago, Illinois
Showing 1–4 of 4 trials
Recruiting
Phase 1
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Phase 2
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Crohn DiseaseColitis Ulcerative
Eli Lilly and Company60 enrolled72 locationsNCT07483073
Recruiting
Phase 2
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Crohn Disease
Eli Lilly and Company60 enrolled72 locationsNCT07483099
Recruiting
Not Applicable
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Crohn DiseaseUlcerative Colitis
University of California, San Diego250 enrolled22 locationsNCT05230173